Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo.

por Brain, E. G., Yu, L. J., Gustafsson, K., Drewes, P., Waxman, D. J.
Publicado 1998

A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

por Zelek, L, Yovine, A, Brain, E, Turpin, F, Taamma, A, Riofrio, M, Spielmann, M, Jimeno, J, Misset, J L
Publicado 2006

Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions

por Schagen, S.B., Klein, M., Reijneveld, J.C., Brain, E., Deprez, S., Joly, F., Scherwath, A., Schrauwen, W., Wefel, J.S.
Publicado 2014

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

por Porte, B., Carton, M., Lerebours, F., Brain, E., Loirat, D., Haroun, L., Bellesoeur, A., Bach Hamba, S., Kirova, Y., Cottu, P.
Publicado 2020

Effect of Electroacupuncture on Hyperalgesia and Vasoactive Neurotransmitters in a Rat Model of Conscious Recurrent Migraine

por Xu, Xiaobai, Liu, Lu, Zhao, Luopeng, Li, Bin, Jing, Xianghong, Qu, Zhengyang, Zhu, Yupu, Zhang, Yajie, Li, Zhijuan, Fisher, Marc, Cairns, Brain E., Wang, Linpeng
Publicado 2019

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

por Brain, E., Garrino, C., Misset, J. L., Carbonero, I. G., Itzhaki, M., Cvitkovic, E., Goldschmidt, E., Burki, F., Regensberg, C., Pappo, E., Hagipantelli, R., Musset, M.
Publicado 1997

Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer(†)

por O'Shaughnessy, J., Campone, M., Brain, E., Neven, P., Hayes, D., Bondarenko, I., Griffin, T. W., Martin, J., De Porre, P., Kheoh, T., Yu, M. K., Peng, W., Johnston, S.
Publicado 2016

High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer

por Brain, E, Levy, C, Serin, D, Roché, H, Spielmann, M, Delva, R, Veyret, C, Mauriac, L, Rios, M, Martin, A L, Jimenez, M, Asselain, B, Gauthier, M, Bonnetain, F, Fumoleau, P
Publicado 2011

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

por Brain, E, Isambert, N, Dalenc, F, Diéras, V, Bonneterre, J, Rezai, K, Jimenez, M, Mefti-Lacheraf, F, Cottura, E, Tresca, P, Vanlemmens, L, Mahier-Aït Oukhatar, C, Lokiec, F, Fumoleau, P
Publicado 2012

Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study

por Benderra, M.-A., Serrano, A.G., Paillaud, E., Tapia, C.M., Cudennec, T., Chouaïd, C., Lorisson, E., de la Taille, A., Laurent, M., Brain, E., Bringuier, M., Gligorov, J., Caillet, P., Canoui-Poitrïne, F.
Publicado 2023

International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

por Wheelwright, S, Darlington, A-S, Fitzsimmons, D, Fayers, P, Arraras, J I, Bonnetain, F, Brain, E, Bredart, A, Chie, W-C, Giesinger, J, Hammerlid, E, O'Connor, S J, Oerlemans, S, Pallis, A, Reed, M, Singhal, N, Vassiliou, V, Young, T, Johnson, C
Publicado 2013

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

por Grinda, T., Antoine, A., Jacot, W., Blaye, C., Cottu, P.-H., Diéras, V., Dalenc, F., Gonçalves, A., Debled, M., Patsouris, A., Mouret-Reynier, M.-A., Mailliez, A., Clatot, F., Levy, C., Ferrero, J.-M., Desmoulins, I., Uwer, L., Petit, T., Jouannaud, C., Lacroix-Triki, M., Deluche, E., Robain, M., Courtinard, C., Bachelot, T., Brain, E., Pérol, D., Delaloge, S.
Publicado 2021